Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
  • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
  • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
  • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
  • C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
• • A—HUMAN NECESSITIES
  • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
  • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
  • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
  • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
  • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
  • C07D493/10—Spiro-condensed systems
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
  • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
  • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen

Definitions

• Avermectin B1 derivatives having an aminosurfonyloxy substituent in the 4"-position having an aminosurfonyloxy substituent in the 4"-position
• the invention relates to (1) a compound of formula
• R 1 is C ⁇ -C ⁇ 2 alkyl, C 3 -C 8 cycloalkyl; or C 2 -C 12 alkenyl;
• R 2 is hydrogen, unsubstituted or mono- to penta-substituted C ⁇ -C 12 alkyl or unsubstituted or mono- to penta-substituted C 2 -C 12 alkenyl; unsubstituted or mono- to penta-substituted C 2 -C 12 alkynyl; -C(O)R 4 or SO 2 R ;
• R 3 is hydrogen, C 1 -C ⁇ 2 alkyl, mono- to penta-substituted d-C 12 alkyl, unsubstituted or mono- to penta-substituted C 3 -C ⁇ 2 cycloalkyl, unsubstituted or mono- to penta-substituted C 2 -C ⁇ 2 alkenyl; or unsubstituted or mono- to penta-substituted C 2 -C 2 alkynyl; or
• R 4 is H, OH, C C 8 alkyl, C C 8 alkyl mono- to hepta-substituted by halogen, nitro, C C 8 alkoxy, OH, SH, NH 2 , NH(d-C 12 alkyl) or N(C C 12 alkyl) 2 ; C C 8 alkoxy, halo-C C 8 - alkoxy, C 3 -C 8 cycloalkyl, C 3 -C 8 cycloalkoxy, C 2 -C 8 alkenyl, C 2 -C 8 alkenyloxy, C 2 -C 8 alkynyl, C 2 -C 8 alkynyloxy, NH 2 , NH(C C 12 alkyl), N(C r C 12 alkyl) 2) aryl, aryloxy, benzyl, benzyloxy, heterocyclyl, heterocyclyloxy, heterocyclylmethyl or heterocyclylmethoxy; wherein the radicals
• R 7 is H, d-C 12 alkyl, d-C 12 haloalkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, phenyl, benzyl, NH 2) NH(C 1 -C ⁇ 2 alkyl), N(d-C 12 alkyl) 2 , NH-phenyl or N(C C 12 alkyl)-phenyl; and
• R 8 is H, OH, C ⁇ -C 12 alkyl, C C 12 alkoxy, Crdalkoxy-CrCealkoxy, C 2 -C 8 alkenyloxy, phenyl, phenoxy, benzyloxy, NH 2 , NH(d-C 12 alkyl), N(C -d 2 alkyl) 2 , NH-phenyl or N(C 1 -C 12 - alkyl)-phenyl; and, where applicable, to E/Z isomers, mixtures of E/Z isomers and/or tautomers, in each case in free form or in salt form; to a process for the preparation of and to the use of those compounds and their isomers and tautomers; to starting materials for the preparation of the compounds of formula (I); to pesticidal compositions in which the active ingredient has been selected from the compounds of formula (I) and their tautomers; and to a method of controlling pests using those compositions.
• Avermectins are known to the person skilled in the art. They are a group of structurally closely related pesticidally active compounds which are obtained by fermentation of a strain of the microorganism Streptomyces avermitilis. Derivatives of avermectins can be obtained via conventional chemical syntheses.
• the avermectins obtainable from Streptomyces avermitilis are designated A1 a, A1 b, A2a, A2b, B1 a, B1 b, B2a and B2b.
• Compounds with the designation "A” have a methoxy radical in the 5-position; those compounds designated “B” have an OH group.
• the "a” series comprises compounds wherein the substituent R-i (in position 25) is a sec-butyl radical; in the "b” series there is an isopropyl radical in the 25-position.
• the number 1 in the name of a compound indicates that atoms 22 and 23 are bonded by a double bond; the number 2 indicates that they are bonded by a single bond and carbon atom 23 carries an OH group.
• the above designations are retained in the description of the present invention in order in the case of the non-natural avermectin derivatives according to the invention to indicate the specific structural type corresponding to natural avermectin.
• derivatives of compounds of the B1 series more especially mixtures of derivatives of avermectin B1 a and B1 b having, at the 4"-position, either the S- or the R-configuration.
• the compounds of formula (I) and, where applicable, their tautomers can form salts, for example acid addition salts.
• These acid addition salts are formed, for example, with strong inorganic acids, such as mineral acids, for example sulfuric acid, a phosphoric acid or a hydrohalic acid, with strong organic carboxylic acids, such as unsubstituted or substituted, for example halo-substituted, d-C 4 alkanecarboxylic acids, for example acetic acid, unsaturated or saturated dicarboxylic acids, for example oxalic acid, malonic acid, maleic acid, fumaric acid or phthalic acid, hydroxycarboxylic acids, for example ascorbic acid, lactic acid, malic acid, tartaric acid or citric acid, or benzoic acid, or with organic sulfonic acids, such as unsubstituted or substituted, for example halo-substituted, d-C 4 alkane- or aryl- s
• Suitable salts with bases are, for example, metal salts, such as alkali metal salts or alkaline earth metal salts, for example sodium, potassium or magnesium salts, or salts with ammonia or with an organic amine, such as morpholine, piperidine, pyrrolidine, a mono-, di- or tri-lower alkyl- amine, for example ethylamine, diethylamine, triethylamine or dimethylpropylamine, or a mono-, di- or trihydroxy-lower alkylamine, for example mono-, di- or tri-ethanolamine.
• Corresponding internal salts may also be formed where appropriate.
• any reference to the free compounds of formula (I) or their salts is to be understood as including, where appropriate, also the corresponding salts or the free compounds of formula (I), respectively.
• the general terms used hereinbefore and hereinafter have the meanings given below.
• carbon-containing groups and compounds each contain from 1 up to and including 6, preferably from 1 up to and including 4, especially 1 or 2, carbon atoms.
• Halogen - as a group per se and as a structural element of other groups and compounds, such as haloalkyl, haloalkoxy and haloalkylthio - is fluorine, chlorine, bromine or iodine, especially fluorine, chlorine or bromine, more especially fluorine or chlorine.
• Alkyl - as a group perse and as a structural element of other groups and compounds, such as haloalkyl, alkoxy and alkylthio - is, in each case giving consideration to the number of carbon atoms contained in the group or compound in question, either straight-chained, i.e. methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl or octyl, or branched, e.g. isopropyl, isobutyl, sec-butyl, tert-butyl, isopentyl, neopentyl or isohexyl.
• Cycloalkyl - as a group perse and as a structural element of other groups and compounds, such as halocycloalkyl, cycloalkoxy and cycloalkylthio - is, in each case giving due consideration to the number of carbon atoms contained in the group or compound in question, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl or cyclooctyl.
• Alkenyl - as a group perse and as a structural element of other groups and compounds - is, giving due consideration to the number of carbon atoms and conjugated or isolated double bonds contained in the group in question, either straight-chained, e.g. vinyl, allyl, 2-butenyl, 3-pentenyl, 1 -hexenyl, 1-heptenyl, 1 ,3-hexadienyl or 1 ,3-octadienyl, or branched, e.g. isopropenyl, isobutenyl, isoprenyl, tert-pentenyl, isohexenyl, isoheptenyl or isooctenyl.
• Alkenyl groups having from 3 to 12, especially from 3 to 6, more especially 3 or 4, carbon atoms are preferred.
• Alkynyl - as a group perse and as a structural element of other groups and compounds - is, in each case giving due consideration to the number of carbon atoms and conjugated or isolated double bonds contained in the group or compound in question, either straight-chained, e.g. ethynyl, propargyl, 2-butynyl, 3-pentynyl, 1-hexynyl, 1-heptynyl, 3- hexen-1-ynyl or 1 ,5-heptadien-3-ynyl, or branched, e.g.
• Halo-substituted carbon-containing groups and compounds such as alkyl, alkenyl, alkynyl, cycloalkyl, alkoxy or alkylthio substituted by halogen, may be partially halogenated or perhalogenated, it being possible in the case of polyhalogenation for the halogen substituents to be the same or different.
• haloalkyl - as a group per se and as a structural element of other groups and compounds, such as haloalkoxy and haloalkylthio - are methyl substituted from one to three times by fluorine, chlorine and/or bromine, such as CHF 2 or CF 3 ; ethyl substituted from one to five times by fluorine, chlorine and/or bromine, such as CH 2 CF 3 , CF 2 CF 3 , CF 2 CCI 3 , CF 2 CHCI 2> CF 2 CHF 2 , CF 2 CFCI 2 , CF 2 CHBr 2 , CF 2 CHCIF, CF 2 CHBrF or CCIFCHCIF; propyl or isopropyl substituted from one to seven times by fluorine, chlorine and/or bromine, such as CH 2 CHBrCH 2 Br, CF 2 CHFCF 3 , CH 2 CF 2 CF 3 or CH(CF 3 ) 2 ; butyl or an iso
• Aryl is especially phenyl, naphthyl, anthracenyl or perylenyl, preferably phenyl.
• Heterocyclyl is especially pyridyl, pyrimidyl, s-triazinyl, 1 ,2,4-triazinyl, thienyl, furyl, tetrahydrofuranyl, pyranyl, tetrahydropyranyl, pyrrolyl, pyrazolyl, imidazolyl, thiazolyl, triazolyl, tetrazolyl, oxazolyl, thiadiazolyl, oxadiazolyl, benzothienyl, quinolinyl, quinoxalinyl, benzo- furanyl, benzimidazolyl, benzopyrrolyl, benzothiazolyl, indolyl, coumarinyl or indazolyl, which are preferably bonded via a carbon atom; preference is given to thienyl, thiazolyl, benzo- furanyl, benzothiazolyl, furyl, tetrahydr
• R 4 is H, OH, C r C 4 alkyl, C C 4 alkoxy, halo-CrC 4 alkyl, halo-CrC 4 alkoxy, C 3 -C 8 cycloalkoxy, C 2 -C 8 alkenyloxy, C 2 -C 8 alkynyloxy, NH 2 , NH(C C 12 alkyl), N(C 1 -d 2 alkyl) 2 , aryl, aryloxy, benzyl or benzyloxy; wherein the radicals aryl, aryloxy, benzyl and benzyloxy are unsubstituted or substituted by from one to three substituents selected independently of one another from halogen, d-C 4 alkyl, C C 4 haloalkyl, d-C 4 alkoxy, d-C 4 haloalkoxy, C C 12 hal
• R 6 is H, CrC 3 alkyl, phenyl or benzyl
• R 7 is H, OH, NH 2 , NH(d-C 12 alkyl), N(C ⁇ -C 12 alkyl) 2 , C C ⁇ 2 alkyl, C C 12 alkoxy, d-Cealkoxy-Ci-C ⁇ alkoxy, C 2 -C 8 alkenyloxy, phenyl, phenoxy, benzyloxy or NH-phenyl;
• the invention further relates to a process for the preparation of the compounds of formula (I) as defined above under (1 ) and, where applicable, tautomers thereof, which comprises
• R 2 and R 3 are as defined above for formula (I) and Hal is a halogen atom, preferably bromine or iodine, and which is known or can be prepared by methods known per se, to form a compound of formula
• the reactions described hereinbefore and hereinafter are carried out in a manner known per se, for example in the absence or, customarily, in the presence of a suitable solvent or diluent or of a mixture thereof, the reactions being carried out, as required, with cooling, at room temperature or with heating, for example in a temperature range of approximately from -80°C to the boiling temperature of the reaction medium, preferably from approximately 0°C to approximately +150°C, and, if necessary, in a closed vessel, under pressure, under an inert gas atmosphere and/or under anhydrous conditions.
• a suitable solvent or diluent or of a mixture thereof the reactions being carried out, as required, with cooling, at room temperature or with heating, for example in a temperature range of approximately from -80°C to the boiling temperature of the reaction medium, preferably from approximately 0°C to approximately +150°C, and, if necessary, in a closed vessel, under pressure, under an inert gas atmosphere and/or under anhydrous conditions.
• reaction time is not critical; a reaction time of from approximately 0.1 to approximately 72 hours, especially from approximately 0.5 to approximately 24 hours, is preferred.
• the product is isolated by customary methods, for example by means of filtration, crystallisation, distillation or chromatography, or any suitable combination of such methods.
• Ri and Q are as defined above are known to the person skilled in the art (abamectin B1a or 4"-ep/ ' -abamectin B1a each provided with a protecting group in the 5-position) or can be prepared by methods known perse.
• solvents and diluents include: aromatic, aliphatic and alicyclic hydrocarbons and halogenated hydrocarbons, such as benzene, toluene, xylene, mesitylene, tetralin, chlorobenzene, dichlorobenzene, bromobenzene, petroleum ether, hexane, cyclo- hexane, dichloromethane, trichloromethane, tetrachloromethane, dichloroethane, trichloro- ethene or tetrachloroethene; ethers, such as diethyl ether, dipropyl ether, diisopropyl ether, dibutyl ether, tert-butyl methyl ether, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol dimethyl ether, dimethoxydiethyl ether, tetrahydro
• Protecting groups Q in the compounds of formulae (II) and (IV) include: alkyl ether radicals, such as methoxymethyl, methylthiomethyl, tert-butylthiomethyl, benzyloxymethyl, p- methoxybenzyl, 2-methoxyethoxymethyl, 2,2,2-trichloroethoxymethyl, 2-(trimethyl- silyl)ethoxymethyl, tetrahydropyranyl, tetrahydrofuranyl, 1 -ethoxyethyl, 1-(2-chloro- ethoxy)ethyl, 1-methyl-1-methoxyethyl, 1 -methyl-1 -benzyloxyethyl, trichloroethyl, 2-tri- methylsilylethyl, tert-butyl, allyl, p-methoxyphenyl, 2,4-dinitrophenyl, benzyl, p-methoxy- benzyl, o-
• trialkylsilyl radicals such as trimethylsilyl, triethylsilyl, dimethyl- tert-butylsilyl, diphenyl-tert-butylsilyl, esters, such as methoxyacetates and phenoxyacetates, and carbonates, such as 9-fluorenylmethylcarbonates and allylcarbonates.
• Dimethyl-tert- butylsilyl ether is especially preferred.
• the reactions are advantageously carried out in a temperature range of from approximately -70°C to 50°C, preferably at from -10°C to 25°C.
• solvents and diluents are the same as those mentioned under Process variant A.
• alcohols such as methanol, ethanol or 2-propanol
• Th e reactions are advantageously carried out in a temperature range of approximately from -70°C to 100°C, preferably at from -10°C to 25°C.
• Lewis acids such as hydrochloric acid, methanesulfonic acid, BF 3 * OEt 2 , HF in pyridine, Zn(BF 4 ) 2 * H 2 O, p-toluenesulfonic acid, AICI 3 , HgCI 2 ; ammonium fluoride, such as tetrabutylammonium fluoride; bases, such as ammonia, trialkylamine or heterocyclic bases; hydrogenolysis with a catalyst, such as palladium-on-carbon; reducing agents, such as sodium borohydride or tributyltin hydride with a catalyst, such as Pd(PPh 3 ) 4 , or also zinc with acetic acid.
• Lewis acids such as hydrochloric acid, methanesulfonic acid, BF 3 * OEt 2 , HF in pyridine, Zn(BF 4 ) 2 * H 2 O, p-toluenesulfonic acid, AICI 3 , Hg
• acids such as methanesulfonic acid or HF in pyridine
• sodium borohydride with Pd(0) bases
• bases such as ammonia, triethylamine or pyridine
• acids such as HF in pyridine or methanesulfonic acid.
• solvents and diluents are the same as those mentioned under Process variant (A).
• alcohols such as methanol, ethanol or 2-propanol, are suitable.
• amides such as dimethylformamide
• nitriles such as acetonitrile; especially acetonitrile.
• the reactions are advantageously carried out in a temperature range of approximately from -10°C to 120°C, preferably at from 20°C to 100°C.
• Suitable bases are especially carbonates, such as sodium carbonate, sodium hydrogen carbonate, potassium carbonate, trialkylamines, such as triethylamine, and heterocyclic bases, such as pyridine.
• Process variants (D) to (F) are carried out substantially analogously to Process variant
• Ethyl acetate and water are preferred.
• the reactions are advantageously carried out in a temperature range of approximately from -10°C to 120°C, preferably at from 20°C to 80°C.
• Suitable bases are especially carbonates, such as sodium carbonate, sodium hydrogen carbonate, potassium carbonate, trialkylamines, such as triethylamine, and heterocyclic bases, such as pyridine.
• the compounds of formula (I) may be in the form of one of the possible isomers or in the form of a mixture thereof, in the form of pure isomers or in the form of an isomeric mixture, i.e. in the form of a racemic mixture; the invention relates both to the pure isomers and to the racemic mixtures and is to be interpreted accordingly hereinbefore and hereinafter, even if stereochemical details are not mentioned specifically in every case.
• racemates can be resolved into the optical antipodes by known methods, for example by recrystallisation from an optically active solvent, by chromatography on chiral adsorbents, for example high pressure liquid chromatography (HPLC) on acetylcellulose, with the aid of suitable microorganisms, by cleavage with specific, immobilised enzymes, or via the formation of inclusion compounds, for example using chiral crown ethers, only one isomer being complexed.
• HPLC high pressure liquid chromatography
• pure optical isomers can be obtained according to the invention also by generally known methods of enantio- selective synthesis, for example by carrying out the process according to the invention using starting materials having correspondingly suitable stereochemistry.
• the compounds of formula (I) may also be obtained in the form of their hydrates and/or may include other solvents, for example solvents which may have been used for the crystallisation of compounds in solid form.
• the invention relates to all those embodiments of the process according to which a compound obtainable as starting material or intermediate at any stage of the process is used as starting material and some or all of the remaining steps are carried out or a starting material is used in the form of a derivative or salt and/or its racemates or antipodes or, especially, is formed under the reaction conditions. ln the processes of the present invention it is preferable to use those starting materials and intermediates which result in the compounds of formula (I) that are especially preferred.
• the invention relates especially to the preparation processes described in the Examples.
• the invention further relates to the compounds of formula (IV) and, where applicable, E/Z isomers, mixtures of E/Z isomers and/or tautomers, in each case in free form or in salt form.
• the compounds of formula (I) according to the invention are active ingredients exhibiting valuable preventive and/or curative activity with a very advantageous biocidal spectrum and a very broad spectrum, even at low rates of concentration, while being well tolerated by warm-blooded animals, fish and plants. They are, surprisingly, equally suitable for controlling both plant pests and ecto- and endo-parasites in humans and more especially in productive livestock, domestic animals and pets. They are effective against all or individual development stages of normally sensitive animal pests, but also of resistant animal pests, such as insects and representatives of the order Acarina, nematodes, cestodes and trematodes, while at the same time protecting useful organisms.
• the insecticidal or acaricidal activity of the active ingredients according to the invention may manifest itself directly, i.e. in the mortality of the pests, which occurs immediately or only after some time, for example during moulting, or indirectly, for example in reduced oviposi- tion and/or hatching rate, good activity corresponding to a mortality of at least 50 to 60 %.
• Suitable additives include, for example, representatives of the following classes of active ingredient: organophosphorus compounds, nitrophenols and derivatives, formamidines, ureas, carba- mates, pyrethroids, chlorinated hydrocarbons, neonicotinoids and Bacillus thuringiensis preparations.
• Examples of especially suitable mixing partners include: azamethiphos; chlorfenvin- phos; cypermethrin, cypermethrin high-cis; cyromazine; diafenthiuron; diazinon; dichlorvos; dicrotophos; dicyclanil; fenoxycarb; fluazuron; furathiocarb; isazofos; iodfenphos; kinoprene; lufenuron; methacriphos; methidathion; monocrotophos; phosphamidon; profenofos; dio- fenolan; a compound obtainable from the Bacillus thuringiensis strain GC91 or from strain NCTC11821 ; pymetrozine; bromopropylate; methoprene; disulfoton; quinalphos; tau- fluvalinate; thiocyclam; thiometon; aldicarb; azin
• the said animal pests include, for example, those mentioned in European Patent Application EP-A-736 252, page 5, line 55, to page 6, line 55.
• the pests mentioned therein are therefore included by reference in the subject matter of the present invention.
• Such pests include, for example, root knot nematodes, cyst-forming nematodes and also stem and leaf nematodes; especially of Heterodera spp., e.g. Heterodera schachtii, Heterodora avenae and Heterodora trifolii; Globodera spp., e.g.
• Globodera rostochiensis Meloidogyne spp., e.g. Meloidogyne incognita and Meloidogyne javanica; Radopholus spp., e.g. Radopholus similis; Pratylenchus, e.g. Pratylenchus neglectans and Pratylenchus penetrans; Tylenchulus, e.g. Tylenchulus semipenetrans; Longidorus, Trichodorus, Xiphinema, Ditylenchus, Apheen- choides and Anguina; especially Meloidogyne, e.g. Meloidogyne incognita, and Heterodera, e.g. Heterodera glycines.
• Meloidogyne spp. e.g. Meloidogyne incognita and Meloidogyne javanica
• An especially important aspect of the present invention is the use of the compounds of formula (I) according to the invention in the protection of plants against parasitic feeding pests.
• the compounds according to the invention can be used to control, i.e. to inhibit or destroy, pests of the mentioned type occurring on plants, especially on useful plants and ornamentals in agriculture, in horticulture and in forestry, or on parts of such plants, such as the fruits, blossoms, leaves, stems, tubers or roots, while in some cases plant parts that grow later are still protected against those pests.
• Target crops include especially cereals, such as wheat, barley, rye, oats, rice, maize and sorghum; beet, such as sugar beet and fodder beet; fruit, e.g. pomes, stone fruit and soft fruit, such as apples, pears, plums, peaches, almonds, cherries and berries, e.g.
• strawberries, raspberries and blackberries leguminous plants, such as beans, lentils, peas and soybeans; oil plants, such as rape, mustard, poppy, olives, sunflowers, coconut, castor oil, cocoa and groundnuts; cucurbitaceae, such as marrows, cucumbers and melons; fibre plants, such as cotton, flax, hemp and jute; citrus fruits, such as oranges, lemons, grapefruit and mandarins; vegetables, such as spinach, lettuce, asparagus, cabbages, carrots, onions, tomatoes, potatoes and paprika; lauraceae, such as avocado, cinnamon and camphor; and tobacco, nuts, coffee, aubergines, sugar cane, tea, pepper, vines, hops, bananas, natural rubber plants and ornamentals.
• the invention therefore relates also to pesticidal compositions, such as emulsifiable concentrates, suspension concentrates, directly sprayable or dilutable solutions, spreadable pastes, dilute emulsions, wettable powders, soluble powders, dispersible powders, wettable powders, dusts, granules and encapsulations of polymer substances, that comprise at least one of the compounds according to the invention, the choice of formulation being made in accordance with the intended objectives and the prevailing circumstances.
• pesticidal compositions such as emulsifiable concentrates, suspension concentrates, directly sprayable or dilutable solutions, spreadable pastes, dilute emulsions, wettable powders, soluble powders, dispersible powders, wettable powders, dusts, granules and encapsulations of polymer substances, that comprise at least one of the compounds according to the invention, the choice of formulation being made in accordance with the intended objectives and the prevailing circumstances.
• the active ingredient is used in those compositions in pure form, a solid active ingredient, for example, in a specific particle size, or preferably together with at least one of the adjuvants customary in formulation technology, such as extenders, e.g. solvents or solid carriers, or surface-active compounds (surfactants).
• extenders e.g. solvents or solid carriers
• surfactants surface-active compounds
• formulation adjuvants there are used, for example, solid carriers, solvents, stabilisers, "slow release” adjuvants, colourings and optionally surface-active substances (surfactants).
• Suitable carriers and adjuvants include all substances customarily used.
• adjuvants such as solvents, solid carriers, surface-active compounds, non-ionic surfactants, cationic surfactants, anionic surfactants and further adjuvants in the compositions used according to the invention, there come into consideration, for example, those described in EP-A-736 252, page 7, line 51 to page 8, line 39.
• surfactants % by weight in each case.
• Dusts active ingredient: 0.1 to 10%, preferably 0.1 to 1 % solid carrier: 99.9 to 90%, preferably 99.9 to 99%
• Suspension concentrates active ingredient: 5 to 75%, preferably 10 to 50% water: 94 to 24%, preferably 88 to 30% surfactant: 1 to 40%, preferably 2 to 30%
• Wettable powders active ingredient: 0.5 to 90%, preferably 1 to 80% surfactant: 0.5 to 20%, preferably 1 to 15% solid carrier: 5 to 99%, preferably 15 to 98%
• Granules active ingredient: 0.5 to 30%, preferably 3 to 15% solid carrier: 99.5 to 70%, preferably 97 to 85%
• compositions according to the invention may also comprise further solid or liquid adjuvants, such as stabilisers, e.g. vegetable oils or epoxidised vegetable oils (e.g. epoxi- dised coconut oil, rapeseed oil or soybean oil), antifoams, e.g. silicone oil, preservatives, viscosity regulators, binders and/or tackifiers as well as fertilisers or other active ingredients for obtaining special effects, e.g. acaricides, bactericides, fungicides, nematicides, mollus- cicides or selective herbicides.
• stabilisers e.g. vegetable oils or epoxidised vegetable oils (e.g. epoxi- dised coconut oil, rapeseed oil or soybean oil), antifoams, e.g. silicone oil, preservatives, viscosity regulators, binders and/or tackifiers as well as fertilisers or other active ingredients for
• the crop protection products according to the invention are prepared in known manner, in the absence of adjuvants, e.g. by grinding, sieving and/or compressing a solid active ingredient or mixture of active ingredients, for example to a certain particle size, and in the presence of at least one adjuvant, for example by intimately mixing and/or grinding the active ingredient or mixture of active ingredients with the adjuvant(s).
• the invention relates likewise to those processes for the preparation of the compositions according to the invention and to the use of the compounds of formula (I) in the preparation of those compositions.
• the invention relates also to the methods of application of the crop protection products, i.e. the methods of controlling pests of the mentioned type, such as spraying, atomising, dusting, coating, dressing, scattering or pouring, which are selected in accordance with the intended objectives and the prevailing circumstances, and to the use of the compositions for controlling pests of the mentioned type.
• Typical rates of concentration are from 0.1 to 1000 ppm, preferably from 0.1 to 500 ppm, of active ingredient.
• the rates of application per hectare are generally from 1 to 2000 g of active ingredient per hectare, especially from 10 to 1000 g/ha, preferably from 20 to 600 g/ha.
• a preferred method of application in the area of crop protection is application to the foliage of the plants (foliar application), the frequency and the rate of application being dependent upon the risk of infestation by the pest in question.
• the active ingredient can also penetrate the plants through the roots (systemic action) when the locus of the plants is impregnated with a liquid formulation or when the active ingredient is incorporated in solid form into the locus of the plants, for example into the soil, e.g. in granular form (soil application). In the case of paddy rice crops, such granules may be applied in metered amounts to the flooded rice field.
• the crop protection products according to the invention are also suitable for protecting plant propagation material, e.g. seed, such as fruits, tubers or grains, or plant cuttings, against animal pests.
• the propagation material can be treated with the composition before planting: seed, for example, can be dressed before being sown.
• the active ingredients according to the invention can also be applied to grains (coating), either by impregnating the seeds in a liquid formulation or by coating them with a solid formulation.
• the composition can also be applied to the planting site when the propagation material is being planted, for example to the seed furrow during sowing.
• the invention relates also to such methods of treating plant propagation material and to the plant propagation material so treated.
• avermectin B1 derivatives mixtures of avermectin B1 a and B1 b derivative
• the B1 b derivative generally represents about only from 5 to 10 % by weight of the mixtures and, for that reason, usually only the bands of the B1 a derivative can be detected in the NMR spectrum.
• the compounds are in most cases in the form of mixtures of the avermectin B1 a and B1 b derivative, characterisation by means of the customary physical data such as melting point or refractive index is of little use. For that reason, the compounds are characterised by means of NMR spectroscopy following purification by chromatography, or by reference to the retention times determined in analysis by means of HPLC (high-resolution liquid chromatography).
• the term "B1 a" in the physical data on the Preparation Examples refers to the main component, wherein R ⁇ is sec-butyl.
• B1 b represents the secondary component, wherein Ri is isopropyl.
• YMC-Pack ODS-AQ column length 125 mm column internal diameter: 2 mm temperature: 40 °C
• the YMC-Pack ODS-AQ column used for chromatography of the compounds is produced by YMC, Alte Raesfelderstrasse 6, 46514 Schermbeck, Germany.
• sulfamoyl chloride (CISO 2 NH 2 ): 15.5 ml of formic acid are added drop- wise at -10°C to 35 ml of chlorosulfonyl isocyanate and the temperature is maintained below +10°C by cooling with ice. At the end of the addition, stirring is continued at room temperature until the evolution of gas ceases. The mixture is taken up in benzene, filtered, and concentrated by evaporation in vacuo, yielding the desired sulfamoyl chloride.
• Step A 3.51 g of sulfamoyl chloride are added in portions at -10°C to a solution of 15 g of 5-O-TBDMS-avermectin B in 90 ml of dimethylacetamide under argon. The mixture is allowed to warm to room temperature and is stirred for a further hour. The mixture is poured onto saturated aqueous NaCI solution, extracted twice with tert-butyl methyl ether, dried over Na 2 SO 4 and concentrated by evaporation, yielding the desired intermediate 5-O-TBDMS-4"- O-sulfamoyloxy-avermectin B ⁇
• Step B The crude product from Step A is dissolved in 75 ml of methanol. Then, at -5°C, 1.5 ml of methanesulfonic acid in 75 ml of methanol are added dropwise in the course of one hour. The mixture is allowed to warm to room temperature and is left to react for four hours. The solution is poured onto saturated aqueous NaHCO 3 solution, concentrated by evaporation in vacuo, and extracted twice with tert-butyl methyl ether. Washing with saturated aqueous NaCI solution, drying over Na 2 SO and concentration by evaporation yield the crude product. Flash column chromatography on silica gel in CH 2 CI 2 /ethyl acetate (9:1 ) yields the desired product in the form of a colourless foam.
• N-methylsulfamoyl chloride (CISO 2 NHMe): 16.9 g of methylamine hydrochloride in 80 ml of acetonitrile are added to a solution of 65 ml of sulfuryl chloride in 50 ml of acetonitrile. After 24 hours at 60°C, the reaction mixture is cooled to room temperature, filtered off and concentrated by evaporation. Vacuum distillation of the resulting brown oil yields the desired product in the form of a colourless oil.
• Step A 240 mg of ⁇ /-methylsulfamoyl chloride are added at 0°C to a solution of 400 mg of 5-O-TBDMS-avermectin B ⁇ in 5 ml of dimethylacetamide under argon, and the mixture is left to react at room temperature for 2 hours. The mixture is poured onto saturated NaCI solution, extracted twice with ethyl acetate, dried over Na 2 SO 4 and concentrated by evaporation, yielding the desired intermediate 5-O-TBDMS-4"-O-(N-methyl)-sulfamoyloxy- avermectin B- ⁇ .
• Step B 1 ml of HF-pyridine reagent (25 g of commercial 70 % HF-pyridine solution, 27.5 ml of tetrahydrofuran, 12.5 ml of pyridine) is added to a solution of the resulting crude product in 5 ml of absolute tetrahydrofuran and the mixture is left to stand at room temperature for 12 hours.
• the reaction mixture is poured onto water and is extracted twice with ether. Washing with saturated NaHCO 3 solution, drying over Na 2 SO 4 and concentration by evaporation yield the crude product. Flash column chromatography on silica gel in hexane/ethyl acetate (1 :1) yields the desired product in the form of a colourless foam.
• Step A 240 mg of ⁇ /-methylsulfamoyl chloride are added at 0°C to a solution of 400 mg of 5-O-TBDMS-avermectin - t in 5 ml of dimethylacetamide under argon, and the mixture is left to react at room temperature for 12 hours.
• the mixture is poured onto saturated NaCI solution, extracted twice with ethyl acetate, dried over Na 2 SO 4 and concentrated by evaporation, yielding the desired intermediate 5-O-TBDMS-4"-O-(N-methyl)-sulfamoyloxy- avermectin B ⁇ .
• Step B 0.2 ml of methanesulfonic acid is added at 0°C to a solution of the crude product obtained in Step A in 1.5 ml of methanol and the mixture is left to react at room temperature for 20 minutes.
• the reaction mixture is poured onto saturated NaHCO 3 solution, concentrated by evaporation, extracted with ethyl acetate, subsequently washed with saturated NaCI solution, dried over Na 2 SO 4 and concentrated by evaporation. Flash column chromatography of the crude product on silica gel in hexane/ethyl acetate (1 :1 ) yields the desired product in the form of a yellow foam.
• a solution of 238 mg of 4"-sulfamoyloxy-avermectin B1 , 138 mg of potassium carbonate and 0.09 ml of bromoacetonitrile in 5 ml of acetonitrile is stirred at room temperature for 10 hours.
• the solution is poured onto water, extracted with ether and dried over Na 2 SO 4 ..
• the desired product is isolated from the crude mixture by column chromatography on silica gel in hexane/ethyl acetate (60:40).
• a mixture of 200 mg of 4"-sulfamoyloxy-avermectin B-i, 0.15 ml of benzoyl chloride in 3 ml of ethyl acetate and 3 ml of saturated aqueous NaHCO 3 solution is stirred at 70°C for 6 hours.
• the mixture is poured onto water, extracted with ether and dried over Na 2 SO 4 .
• the desired product is isolated from the crude mixture by column chromatography on silica gel in hexane/ethyl acetate (1 :1 ).
• Example P.12 Preparation of 4"-ep/ ' -sulfamoyloxy-avermectin B1 of the formula
• R-i sec-butyl (B1a) or isopropyl (B1 b) and R 2 is hydrogen:
• Table 1 A compound of formula (la) wherein R ⁇ is sec-butyl (B1 a) or isopropyl (B1 b), R 3 is hydrogen and R 2 corresponds to one of the radicals of Table B listed under B.1 to B.50.
• Table 2 A compound of formula (lb) wherein R-i is sec-butyl (B1a) or isopropyl (B1 b), R 3 is hydrogen and R 2 corresponds to one of the radicals of Table B listed under B.1 to B.50.
• Table 5 A compound of formula (la) wherein Ri is sec-butyl (B1 a) or isopropyl (B1 b), and R 2 and R 3 correspond to one of the radicals of Table D listed under D.1 to D.016.
• Example F1 Emulsifiable concentrates a) b) c) active ingredient 25% 40% 50% calcium dodecylbenzenesulfonate 5% 8% 6% castor oil polyethylene glycol ether (36 mol EO) 5% - - tributylphenol polyethylene glycol ether (30 mol EO) - 12% 4% cyclohexanone - 15% 20% xylene mixture 65% 25% 20%
• Example F2 Solutions a) b) c) d) active ingredient 80% 10% , 5% 95% ethylene glycol monomethyl ether 20% _ _ polyethylene glycol (MW 400) - 70%
• Example F3 Granules a) b) c) d) active ingredient 5% 10% 8% 21 % kaolin 94% - 79% 54% highly dispersed silicic acid 1 % - 13% 7% attapulgite - 90% _ 18%
• Example F4 Wettable powders a) b) c) active ingredient 25% 50% 75% sodium lignosulfonate 5% 5% - sodium lauryl sulfate 3% - 5% sodium diisobutylnaphthalenesulfonate - 6% 10% octylphenol polyethylene glycol ether (7-8 mol EO) - 2% - highly dispersed silicic acid 5% 10% 10% kaolin 62% 27% -
• Active ingredient and additives are mixed together and the mixture is ground in a suitable mill, yielding wettable powders that can be diluted with water to form suspensions of the desired concentration.
• Example F5 Emulsifiable concentrate active ingredient 10% octylphenol polyethylene glycol ether (4-5 mol EO) 3% calcium dodecylbenzenesulfonate 3% castor oil polyethylene glycol ether (36 mol EO) 4% cyclohexanone 30% xylene mixture 50%
• Example F6 Extruder granules active ingredient 10% sodium lignosulfonate 2% carboxymethylcellulose 1 % kaolin 87%
• Active ingredient and additives are mixed together, the mixture is ground, moistened with water, extruded and granulated and the granules are dried in a stream of air.
• Example F7 Coated granules active ingredient 3% polyethylene glycol (MW 200) 3% kaolin 94% Uniform application of the finely ground active ingredient to the kaolin moistened with polyethylene glycol in a mixer yields non-dusty coated granules.
• Example F8 Suspension concentrate active ingredient 40% ethylene glycol 10% nonylphenol polyethylene glycol ether (15 mol EO) 6% sodium lignosulfonate 10% carboxymethylcellulose 1 % aqueous formaldehyde solution (37%) 0.2% aqueous silicone oil emulsion (75%) 0.8% water 32%
• Example B1 Action against Spodoptera littoralis
• Young soybean plants are sprayed with an aqueous emulsion spray mixture comprising 12.5 ppm of test compound and, after the spray-coating has dried, the plants are populated with 10 caterpillars of Spodoptera littoralis in the first stage and then placed in a plastics container. 3 days later, the percentage reduction in population and the percentage reduction in feeding damage (% activity) are determined by comparing the number of dead caterpillars and the feeding damage on the treated plants with that on untreated plants.
• Example B2 Action against Spodoptera littoralis. systemic:
• Maize seedlings are placed in the test solution. 6 days later, the leaves are cut off, placed on moist filter paper in a petri dish and infested with 12 to 15 Spodoptera littoralis larvae in the Li stage. 4 days later, the percentage reduction in population (% activity) is determined by comparing the number of dead caterpillars on treated plants with that on untreated plants.
• Example B4 Action against Plutella xylostella caterpillars
• Young cabbage plants are sprayed with an aqueous emulsion spray mixture comprising 12.5 ppm of test compound. After the spray-coating has dried, the cabbage plants are populated with 10 caterpillars of Plutella xylostella in the first stage and placed in a plastics container. Evaluation is made 3 days later. The percentage reduction in population and the percentage reduction in feeding damage (% activity) are determined by comparing the number of dead caterpillars and the feeding damage on the treated plants with that on the untreated plants.
• Maize seedlings are sprayed with an aqueous emulsion spray mixture comprising 12.5 ppm of the test compound and, after the spray-coating has dried, the maize seedlings are populated with 10 Diabrotica balteata larvae in the second stage and then placed in a plastics container. 6 days later, the percentage reduction in population (% activity) is determined by comparing the number of dead larvae on the treated plants with that on untreated plants.
• Example B6 Action against Tetranychus urticae
• Young bean plants are populated with a mixed population of Tetranychus urticae and sprayed one day later with an aqueous emulsion spray mixture comprising 12.5 ppm of test compound. The plants are incubated for 6 days at 25°C and subsequently evaluated. The percentage reduction in population (% activity) is determined by comparing the number of dead eggs, larvae and adults on the treated plants with that on untreated plants.

Landscapes

• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Life Sciences & Earth Sciences (AREA)
• Health & Medical Sciences (AREA)
• Engineering & Computer Science (AREA)
• General Health & Medical Sciences (AREA)
• Biochemistry (AREA)
• Biotechnology (AREA)
• Genetics & Genomics (AREA)
• Molecular Biology (AREA)
• Agronomy & Crop Science (AREA)
• Pest Control & Pesticides (AREA)
• Plant Pathology (AREA)
• Dentistry (AREA)
• Wood Science & Technology (AREA)
• Zoology (AREA)
• Environmental Sciences (AREA)
• Agricultural Chemicals And Associated Chemicals (AREA)
• Saccharide Compounds (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Priority Applications (14)

Applications Claiming Priority (4)

Publications (2)

Family

ID=25738950

Family Applications (1)

Country Status (26)

Cited By (10)

Families Citing this family (10)

Family Cites Families (1)

• 2002
  • 2002-12-19 AR ARP020105025A patent/AR037938A1/es not_active Application Discontinuation
  • 2002-12-19 TW TW091136626A patent/TW200301079A/zh unknown
  • 2002-12-20 RU RU2004122622/04A patent/RU2004122622A/ru not_active Application Discontinuation
  • 2002-12-20 DK DK02796710T patent/DK1456218T3/da active
  • 2002-12-20 PT PT02796710T patent/PT1456218E/pt unknown
  • 2002-12-20 ES ES02796710T patent/ES2307823T3/es not_active Expired - Lifetime
  • 2002-12-20 MX MXPA04006121A patent/MXPA04006121A/es unknown
  • 2002-12-20 CA CA002469905A patent/CA2469905A1/en not_active Abandoned
  • 2002-12-20 US US10/498,858 patent/US6933260B2/en not_active Expired - Lifetime
  • 2002-12-20 HU HU0402290A patent/HUP0402290A2/hu unknown
  • 2002-12-20 WO PCT/EP2002/014671 patent/WO2003053988A2/en not_active Ceased
  • 2002-12-20 NZ NZ533584A patent/NZ533584A/en unknown
  • 2002-12-20 CN CNA028258835A patent/CN1608075A/zh active Pending
  • 2002-12-20 BR BR0215170-7A patent/BR0215170A/pt not_active Application Discontinuation
  • 2002-12-20 AU AU2002361197A patent/AU2002361197A1/en not_active Abandoned
  • 2002-12-20 KR KR10-2004-7009873A patent/KR20040068335A/ko not_active Withdrawn
  • 2002-12-20 PL PL02370835A patent/PL370835A1/xx not_active Application Discontinuation
  • 2002-12-20 EP EP02796710A patent/EP1456218B1/en not_active Expired - Lifetime
  • 2002-12-20 JP JP2003554704A patent/JP2005513137A/ja active Pending
  • 2002-12-20 IL IL16245202A patent/IL162452A0/xx unknown
  • 2002-12-20 DE DE60226895T patent/DE60226895D1/de not_active Expired - Lifetime
  • 2002-12-20 AT AT02796710T patent/ATE397007T1/de active
  • 2002-12-20 SI SI200230716T patent/SI1456218T1/sl unknown
• 2004
  • 2004-06-15 CO CO04055633A patent/CO5590963A2/es not_active Application Discontinuation
  • 2004-07-19 MA MA27793A patent/MA26300A1/fr unknown
• 2008
  • 2008-08-18 CY CY20081100877T patent/CY1108269T1/el unknown

Also Published As

Similar Documents

Legal Events